Eurofins Scientific SE/ FR0014000MR3 /
| 1/24/2025 3:14:19 PM | Chg. +0.19 | Volume | Bid3:14:57 PM | Ask3:15:03 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 48.05EUR | +0.40% | 95,351 Turnover: 2.25 mill. |
48.05Bid Size: 169 | 48.06Ask Size: 56 | 9.27 bill.EUR | 1.04% | 16.24 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 2.96 EUR | -17.09% |
| EPS Diluted: | - EUR | -16.52% |
| Revenues per Share: | 33.77 EUR | -3.14% |
| Book Value per Share: | 26.32 EUR | 5.96% |
| Cash Flow per Share: | 5.28 EUR | -10.61% |
| Dividend per Share: | 0.50 EUR | -50.00% |
| Total | in mill. | |
| Revenues: | 6,514.60 EUR | -2.94% |
| Net Income: | 570.20 EUR | -17.05% |
| Operating Cash Flow: | 1,017.90 EUR | - |
| Cash and Cash Equivalents: | 1,221.20 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 16.24 | 19.93 |
| P/S Ratio: | 1.42 | 1.75 |
| P/BV ratio: | 1.83 | 2.24 |
| P/CF Ratio: | 9.11 | 11.18 |
| PEG: | -0.95 | -1.17 |
| Earnings Yield: | 6.16% | 5.02% |
| Dividend Yield: | 1.04% | 0.85% |
| Market Capitalization | ||
| Market Capitalization: | 9.27 bill. EUR | 11.38 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 150,079.8084 EUR | 184,103.7250 EUR |
| Shares Outstanding: | 192.9 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 12.92% |
| Net Profit Margin: | 8.75% |
| Return on Equity: | 11.23% |
| Return on Assets: | 5.24% |
Financial Strength
| Liquidity I / Cash Ratio: | 57.56% |
| Liquidity II / Quick Ratio: | 108.12% |
| Liquidity III / Current Ratio: | 144.53% |
| Debt / Equity Ratio: | 114.45% |
| Dynam. Debt / Equity Ratio: | 570.89% |
Efficiency
| Employees: | 61,798 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 105,417.65 EUR |
| Net Income / Employee: | 9,226.84 EUR |
| Total Assets / Employee: | 176,196.64 EUR |
| * Fiscal Year End: | 12/31/2023 |
| Accounting Standard: | IFRS |
| Currency: | EUR |